Episode 4 - Supportive Pharmacotherapy for Prevalent Co-morbidities
Part IV of the course in pharmacotherapy in atrial fibrillation (AF) is exploring the fact that AF no longer is viewed as a solitary disease, but is strongly intertwined with a number of lifestyle conditions. The course will cover the relationships of AF to some of these conditions, and will provide evidence that lifestyle modifications per se can lead to better success rates in keeping patients in sinus rhythm whenever rhythm control strategy is chosen. Of course, this includes cardiovascular preventive pharmacotherapies for prevalent co-morbidities such as arterial hypertension, diabetes and heart failure.
A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on...Read More
A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on Wondr Medical. Dan Atar speaks about clinical cardiology topics, covering areas such as acute coronary syndromes, heart failure, atrial fibrillation, and secondary prevention. Further, he has a particular interest in pharmacotherapy.Show Less